Case StudyClinical JUL 01, 2023
A late-stage biotechnology company developing a next-generation vaccine against COVID-19 was set to conduct a large Phase III trial. The trial design was aligned with other Phase III trials conducted under the auspices of Operation Warp Speed. Citeline Connect was selected to support the trial’s 30,000-participant goal.
Your campaign has been very successful for us!
Discover relevant products
Citeline Connect
The end-to-end solution to find, educate, engage, and enroll clinical trial participants worldwide
Citeline Connect Marketplace
A robust recruitment network of 100+ recruitment organizations powering more efficient, effective trial enrollment
Trial Portfolio Websites
The comprehensive solution for educating, engaging and enrolling participants across an entire clinical trial portfolio
Related Resources